Publicaciones en colaboración con investigadores/as de Stanford University School of Medicine (1)

2023

  1. Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer

    Nature Communications, Vol. 14, Núm. 1